Trials / Unknown
UnknownNCT04934059
Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS).
A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Yuxuebi tablet in treating night pain of Ankylosing Spondylitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Yuxuebi tablet | 0.5g/ tablet |
| DRUG | Placebo tablet | 0.5g/ tablet |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2022-01-31
- Completion
- 2022-01-31
- First posted
- 2021-06-22
- Last updated
- 2021-06-22
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04934059. Inclusion in this directory is not an endorsement.